首页> 外文期刊>BMC Cancer >The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer
【24h】

The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer

机译:与可切除结直肠癌中其他炎症生物标志物相比,术前中性粒细胞与淋巴细胞的比率是预后的较好指标

获取原文
获取外文期刊封面目录资料

摘要

Growing evidence has indicated that some inflammatory markers, including lymphocyte to monocyte ratio (LMR), neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), and prognostic nutritional index (PNI), can be used as indicators in the prognosis of colorectal cancer (CRC). However, there is controversy concerning what is the best predictor of prognosis in CRC. A cohort of 1744 CRC patients in our institution was analyzed retrospectively. Harrell’s concordance index (c-index) and Bayesian information criterion (BIC) were used to determine the optimal cut-off values of inflammatory markers and compare their predictive capacity. The association of inflammatory markers with overall survival (OS) and cancer-specific survival (CSS) was analyzed using Kaplan-Meier methods with log-rank test, followed by multivariate Cox proportional hazards model. The multivariate analysis indicated that among these inflammatory markers, NLR (< 2.0 vs. ≥ 2.0) was the only independent prognostic factor for poor OS [hazard ratio (HR)?=?0.758, 95% confidence intervals (CI)?=?0.598–0.960, P?=?0.021)] and CSS (HR?=?0.738, 95% CI?=?0.573–0.950, P?=?0.018). Among these inflammatory markers, the c-index and BIC value for NLR were maximum and minimum for OS, respectively. In addition, the c-index was higher and the BIC value was smaller in TNM staging combined with NLR compared with the values obtained in TNM staging alone. NLR is a superior indicator of prognosis compared with LMR, PLR, and PNI in CRC patients, and NLR may serve as an additional indicator based on the current tumor staging system.
机译:越来越多的证据表明,某些炎症标志物,包括淋巴细胞与单核细胞的比率(LMR),嗜中性白细胞与淋巴细胞的比率(NLR),血小板与淋巴细胞的比率(PLR)以及预后营养指数(PNI),可以用作预后的指标。大肠癌(CRC)。然而,关于什么是CRC预后的最佳预测指标存在争议。回顾性分析了我们机构中的1744名CRC患者。 Harrell的一致性指数(c-index)和贝叶斯信息标准(BIC)用于确定炎症标记物的最佳临界值,并比较其预测能力。使用Kaplan-Meier方法和对数秩检验,然后采用多元Cox比例风险模型,分析了炎症标志物与总生存期(OS)和癌症特异性生存期(CSS)的关联。多因素分析表明,在这些炎症指标中,NLR(<2.0 vs.≥2.0)是OS不良的唯一独立预后因素[危险比(HR)≤0.758,95%置信区间(CI)≤0.598)。 –0.960,P <= 0.021)]和CSS(HR = 0.738,95%CI = 0.573-0.950,P = 0.018)。在这些炎症标志物中,NLR的c-index和BIC值分别为OS的最大值和最小值。此外,与单独使用TNM分期获得的值相比,与NLR结合使用的TNM分期的c指数更高,BIC值更小。与CRC患者的LMR,PLR和PNI相比,NLR是更好的预后指标,并且基于当前的肿瘤分期系统,NLR可以作为其他指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号